Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply

A. H. Talal, J. Lafleur, R. S. Hoop, P. Pandya, P. Martin, I. M. Jacobson, J. Han, E. J. Korner

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply'. Together they form a unique fingerprint.